In addition to the breast and ovarian cancer risks, there is evidence that BRCA1 and BRCA2 mutations confer increased risks of other cancers such as prostate cancer and pancreatic cancer (The Breast Cancer Linkage Consortium, 1999; Thompson and Easton, 2002). This evidence concerns the gene BRCA2 and pancreatic neoplasm.